DK0475394T3 - Rotte C-type natriuretisk peptid cDNA, og precursorprotein - Google Patents

Rotte C-type natriuretisk peptid cDNA, og precursorprotein

Info

Publication number
DK0475394T3
DK0475394T3 DK91115393.0T DK91115393T DK0475394T3 DK 0475394 T3 DK0475394 T3 DK 0475394T3 DK 91115393 T DK91115393 T DK 91115393T DK 0475394 T3 DK0475394 T3 DK 0475394T3
Authority
DK
Denmark
Prior art keywords
rat
precursor protein
type natriuretic
natriuretic peptide
peptide cdna
Prior art date
Application number
DK91115393.0T
Other languages
English (en)
Inventor
Hisayuki Matsuo
Kenji Kangawa
Masayasu Kojima
Naoto Minamino
Original Assignee
Hisayuki Matsuo
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisayuki Matsuo, Suntory Ltd filed Critical Hisayuki Matsuo
Application granted granted Critical
Publication of DK0475394T3 publication Critical patent/DK0475394T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK91115393.0T 1990-09-11 1991-09-11 Rotte C-type natriuretisk peptid cDNA, og precursorprotein DK0475394T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP02241074A JP3026352B2 (ja) 1990-09-11 1990-09-11 ラットＣＮＰｃＤＮＡ及び前駆体蛋白

Publications (1)

Publication Number Publication Date
DK0475394T3 true DK0475394T3 (da) 1997-07-07

Family

ID=17068911

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91115393.0T DK0475394T3 (da) 1990-09-11 1991-09-11 Rotte C-type natriuretisk peptid cDNA, og precursorprotein

Country Status (8)

Country Link
US (1) US5973134A (da)
EP (1) EP0475394B1 (da)
JP (1) JP3026352B2 (da)
AT (1) ATE154387T1 (da)
DE (1) DE69126487T2 (da)
DK (1) DK0475394T3 (da)
ES (1) ES2104639T3 (da)
GR (1) GR3024580T3 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142118A0 (en) * 2001-03-20 2002-03-10 Prochon Biotech Ltd Method and composition for treatment of skeletal dysplasias
CN1960757A (zh) 2004-03-31 2007-05-09 中尾一和 身高增加用组合物
CN1960758B (zh) 2004-03-31 2014-10-22 中外制药株式会社 关节炎的治疗剂或预防剂
DE602005027461D1 (de) 2004-04-21 2011-05-26 Enobia Pharma Inc Konjugate zur zuführung an knochen und verfahren zu deren verwendung beim hinführen von proteinen zum knochen
JP6055779B2 (ja) 2010-12-27 2016-12-27 アレクシオン ファーマシューティカルズ， インコーポレイテッド ナトリウム利尿ペプチドを含む組成物およびその使用方法
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10822596B2 (en) 2014-07-11 2020-11-03 Alexion Pharmaceuticals, Inc. Compositions and methods for treating craniosynostosis
JP6787894B2 (ja) 2014-12-05 2020-11-18 アレクシオン ファーマシューティカルズ， インコーポレイテッド 組換えアルカリホスファターゼを用いた発作の処置
JP6868561B2 (ja) 2015-01-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼ欠損を有する被験者を治療する方法
JP6993961B2 (ja) 2015-08-17 2022-01-14 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼの製造
EP3355904A4 (en) 2015-09-28 2019-06-12 Alexion Pharmaceuticals, Inc. IDENTIFICATION OF EFFECTIVE DOSE SHEETS FOR TISSUE-SPECIFIC ALKALINE PHOSPHATASE ENZYMERSAT THERAPY OF HYPOPHOSPHATASIA
WO2017074466A1 (en) 2015-10-30 2017-05-04 Alexion Pharmaceuticals, Inc. Methods for treating craniosynostosis in a patient
WO2017155569A1 (en) 2016-03-08 2017-09-14 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
KR20240160671A (ko) 2016-04-01 2024-11-11 알렉시온 파마슈티칼스, 인코포레이티드 알칼리성 포스파타아제로 근육 약화의 치료
US10898549B2 (en) 2016-04-01 2021-01-26 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
EP3464573B1 (en) 2016-06-06 2026-03-04 Alexion Pharmaceuticals, Inc. Metal impact on manufacturing of alkaline phosphatases
EP3500289B1 (en) 2016-08-18 2024-10-09 Alexion Pharmaceuticals, Inc. Asfotase alfa for use in treating tracheobronchomalacia
KR20190129058A (ko) 2017-03-31 2019-11-19 알렉시온 파마슈티칼스, 인코포레이티드 성인 및 청소년에서 저포스파타제증 (hpp)을 치료하는 방법
US11913039B2 (en) 2018-03-30 2024-02-27 Alexion Pharmaceuticals, Inc. Method for producing recombinant alkaline phosphatase
ES2972119T3 (es) 2018-08-10 2024-06-11 Alexion Pharma Inc Cicatrización ósea en implantes utilizando fosfatasa alcalina
KR20220111693A (ko) 2019-12-09 2022-08-09 알렉시온 파마슈티칼스, 인코포레이티드 알칼리성 포스파타제 폴리펩티드 및 이의 이용 방법
US12083169B2 (en) 2021-02-12 2024-09-10 Alexion Pharmaceuticals, Inc. Alkaline phosphatase polypeptides and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3026351B2 (ja) * 1990-07-13 2000-03-27 壽之 松尾 ブタｃｎｐ遺伝子及び前駆体蛋白

Also Published As

Publication number Publication date
US5973134A (en) 1999-10-26
ATE154387T1 (de) 1997-06-15
ES2104639T3 (es) 1997-10-16
JP3026352B2 (ja) 2000-03-27
DE69126487D1 (de) 1997-07-17
EP0475394B1 (en) 1997-06-11
EP0475394A3 (en) 1992-09-16
DE69126487T2 (de) 1997-11-27
GR3024580T3 (en) 1997-12-31
JPH04121190A (ja) 1992-04-22
EP0475394A2 (en) 1992-03-18

Similar Documents

Publication Publication Date Title
DK0475394T3 (da) Rotte C-type natriuretisk peptid cDNA, og precursorprotein
ATE154641T1 (de) Neues physiologisch aktives schweinepeptid (cnp- 53)
DK0466175T3 (da) Porcint CNP-gen og præcursor-protein
ATE68503T1 (de) Atriale peptide.
AU6286986A (en) Peptide analogues of mammalian insulin-like growth factor-1
DK161097C (da) Modificeret faktor vii/viia, dna-sekvens, som koder herfor, ekspressionsvektor indeholdende en saadan dna-sekvens, celle, der er transformeret med en saadan vektor og fremgangsmaade til fremstilling af modificeret faktor vii/viia
DK0859785T3 (da) Cycliske peptidanaloge af somatostatin
ES2196088T3 (es) Analogos del factor de crecimiento de los queratinocitos.
DE69029377D1 (de) Substituierungsanaloge von magaininpeptiden
GR3017297T3 (en) Novel substrate peptides.
EP0298732A3 (en) Therapeutic somatostatin analogues
DK0732339T3 (da) Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf
ATE46173T1 (de) Pharmakologisch aktive peptide.
GB2361923A (en) Novel protein
EP0266006A3 (en) Novel hypotensive diuretic peptides
DK0570244T3 (da) Fremgangsmåde til fremstilling af peptider, der har et C-terminalt prolinamid
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
DK53290A (da) Syntetiske gaer-leader-peptider